News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,632 Results
Type
Article (40702)
Company Profile (280)
Press Release (671639)
Multimedia
Podcasts (74)
Webinars (15)
Section
Business (205353)
Career Advice (2028)
Deals (35586)
Drug Delivery (101)
Drug Development (81409)
Employer Resources (172)
FDA (16321)
Job Trends (14962)
News (347073)
Policy (32774)
Tag
Academia (2575)
Accelerated approval (14)
Adcomms (24)
Allergies (108)
Alliances (49921)
ALS (125)
Alzheimer's disease (1521)
Antibody-drug conjugate (ADC) (171)
Approvals (16369)
Artificial intelligence (355)
Autoimmune disease (40)
Automation (23)
Bankruptcy (364)
Best Places to Work (11657)
BIOSECURE Act (20)
Biosimilars (133)
Biotechnology (189)
Bladder cancer (112)
Brain cancer (39)
Breast cancer (409)
Cancer (3294)
Cardiovascular disease (266)
Career advice (1701)
Career pathing (32)
CAR-T (206)
CDC (37)
Cell therapy (550)
Cervical cancer (27)
Clinical research (67579)
Collaboration (1188)
Company closure (4)
Compensation (832)
Complete response letters (36)
COVID-19 (2674)
CRISPR (67)
C-suite (475)
Cystic fibrosis (122)
Data (3675)
Decentralized trials (2)
Denatured (27)
Depression (81)
Diabetes (387)
Diagnostics (6507)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (164)
Drug pricing (138)
Drug shortages (28)
Duchenne muscular dystrophy (170)
Earnings (88667)
Editorial (44)
Employer branding (21)
Employer resources (148)
Events (115131)
Executive appointments (896)
FDA (18451)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1051)
Gene editing (148)
Generative AI (25)
Gene therapy (429)
GLP-1 (839)
Government (4585)
Grass and pollen (5)
Guidances (330)
Healthcare (18871)
HIV (42)
Huntington's disease (32)
IgA nephropathy (47)
Immunology and inflammation (187)
Immuno-oncology (14)
Indications (45)
Infectious disease (2868)
Inflammatory bowel disease (166)
Inflation Reduction Act (12)
Influenza (78)
Intellectual property (156)
Interviews (314)
IPO (16637)
IRA (50)
Job creations (3674)
Job search strategy (1436)
Kidney cancer (13)
Labor market (63)
Layoffs (528)
Leadership (22)
Legal (7970)
Liver cancer (83)
Longevity (11)
Lung cancer (476)
Lymphoma (242)
Machine learning (22)
Management (58)
Manufacturing (506)
MASH (106)
Medical device (13568)
Medtech (13585)
Mergers & acquisitions (19750)
Metabolic disorders (944)
Multiple sclerosis (110)
NASH (16)
Neurodegenerative disease (154)
Neuropsychiatric disorders (38)
Neuroscience (2327)
NextGen: Class of 2025 (6553)
Non-profit (4503)
Now hiring (53)
Obesity (462)
Opinion (234)
Ovarian cancer (111)
Pain (137)
Pancreatic cancer (143)
Parkinson's disease (198)
Partnered (24)
Patents (363)
Patient recruitment (259)
Peanut (52)
People (58342)
Pharmaceutical (66)
Pharmacy benefit managers (21)
Phase I (21048)
Phase II (29776)
Phase III (22136)
Pipeline (2381)
Policy (233)
Postmarket research (2565)
Preclinical (8979)
Press Release (64)
Prostate cancer (161)
Psychedelics (39)
Radiopharmaceuticals (255)
Rare diseases (522)
Real estate (5972)
Recruiting (66)
Regulatory (23175)
Reports (51)
Research institute (2343)
Resumes & cover letters (351)
Rett syndrome (11)
RNA editing (14)
RSV (55)
Schizophrenia (106)
Series A (176)
Series B (129)
Service/supplier (13)
Sickle cell disease (68)
Special edition (19)
Spinal muscular atrophy (148)
Sponsored (34)
Startups (3651)
State (2)
Stomach cancer (14)
Supply chain (86)
Tariffs (72)
The Weekly (45)
Vaccines (866)
Venture capital (61)
Weight loss (290)
Women's health (51)
Worklife (17)
Date
Today (106)
Last 7 days (426)
Last 30 days (2233)
Last 365 days (30980)
2025 (21664)
2024 (35328)
2023 (40179)
2022 (51289)
2021 (55834)
2020 (54154)
2019 (46643)
2018 (35126)
2017 (32222)
2016 (31630)
2015 (37707)
2014 (31454)
2013 (26500)
2012 (28771)
2011 (29426)
2010 (27525)
Location
Africa (728)
Alabama (69)
Alaska (7)
Arizona (258)
Arkansas (13)
Asia (38670)
Australia (6319)
California (8559)
Canada (2635)
China (774)
Colorado (358)
Connecticut (362)
Delaware (224)
Europe (83285)
Florida (1273)
Georgia (285)
Hawaii (2)
Idaho (61)
Illinois (682)
India (39)
Indiana (403)
Iowa (17)
Japan (259)
Kansas (115)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1133)
Massachusetts (6253)
Michigan (264)
Minnesota (506)
Mississippi (4)
Missouri (101)
Montana (28)
Nebraska (25)
Nevada (98)
New Hampshire (69)
New Jersey (2330)
New Mexico (28)
New York (2315)
North Carolina (1190)
North Dakota (8)
Northern California (3875)
Ohio (263)
Oklahoma (16)
Oregon (36)
Pennsylvania (1802)
Puerto Rico (17)
Rhode Island (41)
South America (1102)
South Carolina (43)
South Dakota (1)
Southern California (3290)
Tennessee (138)
Texas (1319)
United States (31123)
Utah (252)
Virginia (211)
Washington D.C. (75)
Washington State (710)
West Virginia (4)
Wisconsin (71)
712,632 Results for "prometheus bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Press Releases
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds
September 12, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Update 2025
August 15, 2025
·
8 min read
Press Releases
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
September 16, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
August 14, 2025
·
6 min read
Deals
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.
April 16, 2023
·
12 min read
Press Releases
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 16, 2025
·
5 min read
Press Releases
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
July 17, 2025
·
6 min read
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Press Releases
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
August 18, 2025
·
3 min read
1 of 71,264
Next
